BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Isis Pharma (ISIS) Reports Financial Results And Highlights For First Quarter 2015 5/5/2015 10:08:09 AM
Bayer HealthCare (BAY) Licenses Investigational ISIS FXI(Rx) From Isis Pharma (ISIS) To Develop And Commercialize For The Prevention Of Thrombosis 5/4/2015 8:57:41 AM
Isis Pharma (ISIS) Inks $155 Million Bayer (BAY) Deal Just After Good News From Biogen (BIIB) Collaboration 5/4/2015 7:15:11 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $10 Million Milestone Payment From Biogen (BIIB) 5/1/2015 7:44:25 AM
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' First Quarter 2015 Financial Results Conference Call 4/29/2015 11:40:33 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Data From ISIS-TTR Rx In Patients With TTR Amyloidosis 4/23/2015 10:59:11 AM
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 4/10/2015 11:12:42 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 1 Data on Isis-ANGPTL3Rx 3/23/2015 6:35:58 AM
Interleukin Genetics Inc. (ILGN) Expands Its Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 3/9/2015 10:24:22 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $9 Million For Advancing ISIS-SMN Rx In Infants With Spinal Muscular Atrophy 3/6/2015 6:46:48 AM
12345678910...